2024-11-21 12:52:46
extensive studies wee done that show a different outcome [Link] Conclusion: "Pharmaceutical innovation is an international enterprise. Higher prescription drug spending in the United States does not disproportionately privilege domestic innovation" NEEDS_MORE_RATINGS(15-1-30) Author
2024-11-21 13:18:01
The U.S. spends $12,742/person on healthcare (OECD 2022), far more than other wealthy countries. Despite the spending, health outcomes in the U.S. are worse in key metrics. Drug prices are higher because the US gov doesn't regulate them, contrary to other OECD countries. [Link] NEEDS_MORE_RATINGS(31-1-21) Author
2024-11-21 13:56:34
Especially Germany is besides the US and China the most innovative country in the pharma sector and spent about 1.400 € per capita just for pharma research in 2022 [Link] NEEDS_MORE_RATINGS(9-1-23) Author
2024-11-21 15:27:53
This post repeats the 'Free Rider Myth' promoted by multinational Pharmas regarding the need for high US Rx drug prices. [Link] NEEDS_MORE_RATINGS(29-2-21) Author
2024-11-21 18:07:32
NNN - if you disagree with Elon, please post in the comments. Don’t abuse CN to share your point of view. NEEDS_MORE_RATINGS(8-0-6) Author
2024-11-21 23:28:08
NNN - there is extensive research showing that drug companies causally reduce R&D expenditures after price caps. The fact that healthcare is cheaper in other countries does not refute the free rider hypothesis. NEEDS_MORE_RATINGS(2-0-4) Author